UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Hyaluronic Acid-based Supramolecular Nanomedicine with Optimized Ratio of Oxaliplatin/Chlorin e6 for Combined Chemotherapy and O2-Economized Photodynamic Therapy Journal article
Ding YF, Xu X, Li J, Wang Z, Luo J, Mo SP(莫昇萍), Li S, Wang R. Hyaluronic Acid-based Supramolecular Nanomedicine with Optimized Ratio of Oxaliplatin/Chlorin e6 for Combined Chemotherapy and O2-Economized Photodynamic Therapy[J]. Acta Biomaterialia, 2023.
Authors:  Ding YF;  Xu X;  Li J;  Wang Z;  Luo J; et al.
Favorite |   IF:9.4/9.9 | Submit date:2023/03/27
Supramolecular nanomedicine derived from cucurbit [7] uril-conjugated nano-graphene oxide for multi-modality cancer therapy Journal article
Ding, YF, Kwong, C. H. T., Li, S., Pan, Y., Wei, J., Wang, L., Mok, S. P., Wang, R.. Supramolecular nanomedicine derived from cucurbit [7] uril-conjugated nano-graphene oxide for multi-modality cancer therapy[J]. Biomaterials Science, 2021, 9(10), 3804-3813.
Authors:  Ding, YF;  Kwong, C. H. T.;  Li, S.;  Pan, Y.;  Wei, J.; et al.
Favorite | TC[WOS]:31 TC[Scopus]:33  IF:5.8/6.2 | Submit date:2022/07/29
An eco-friendly in situ activatable antibiotic via cucurbit[8]uril-mediated supramolecular crosslinking of branched polyethylenimine. Journal article
Li, S., Jiang, N, Zhao, W, Ding, YF, Zheng, Y, Wang , L.H., Zheng, J., Wang, R.. An eco-friendly in situ activatable antibiotic via cucurbit[8]uril-mediated supramolecular crosslinking of branched polyethylenimine.[J]. Chemical Communications, 2017, 5870-5873.
Authors:  Li, S.;  Jiang, N;  Zhao, W;  Ding, YF;  Zheng, Y; et al.
Favorite | TC[WOS]:56 TC[Scopus]:55 | Submit date:2022/07/29
Activatable Antibiotic  Cucurbit[8]Uril  Supramolecular Crosslinking  Polyethylenimine.  
Naphthalimides induce G2 arrest via the ATM-activated Chk2-executed pathway in HCT116 cells Journal article
Zhu, H, Miao, ZH, Huang, M, Feng, JM, Zhang, ZX, Lu, J., Cai, YJ, Tong, LJ, Xu, YF, Qian, XH, Ding, J. Naphthalimides induce G2 arrest via the ATM-activated Chk2-executed pathway in HCT116 cells[J]. Neoplasia, 2009, 1226-1234.
Authors:  Zhu, H;  Miao, ZH;  Huang, M;  Feng, JM;  Zhang, ZX; et al.
Favorite |  | Submit date:2022/03/31
N/a